Capital Investment Counsel LLC Has $5.37 Million Holdings in Waters Corporation $WAT

Capital Investment Counsel LLC lowered its position in shares of Waters Corporation (NYSE:WAT) by 3.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,581 shares of the medical instruments supplier’s stock after selling 517 shares during the quarter. Capital Investment Counsel LLC’s holdings in Waters were worth $5,374,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Olde Wealth Management LLC acquired a new stake in shares of Waters during the first quarter valued at approximately $25,000. Zions Bancorporation National Association UT purchased a new position in Waters during the first quarter valued at approximately $28,000. IFP Advisors Inc grew its position in Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after purchasing an additional 44 shares in the last quarter. Whipplewood Advisors LLC grew its position in Waters by 5,200.0% during the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier’s stock valued at $39,000 after purchasing an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Waters during the first quarter valued at approximately $41,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

WAT stock opened at $301.89 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $17.97 billion, a price-to-earnings ratio of 27.22, a P/E/G ratio of 2.81 and a beta of 1.07. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The firm has a 50 day moving average of $309.86 and a two-hundred day moving average of $338.14.

Waters (NYSE:WAT) last posted its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. The company had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Ratings Changes

WAT has been the topic of a number of research analyst reports. Wells Fargo & Company lowered their price objective on shares of Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 5th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the company a “hold” rating in a research report on Tuesday, August 5th. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the company a “buy” rating in a research report on Monday, August 4th. Finally, Bank of America boosted their price objective on shares of Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a research report on Thursday, June 26th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $378.73.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.